Takeda Pharmaceutical Co Ltd TAK:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 4:00 PM EDT15.03UNCH (UNCH)
Volume
21,059
Close
15.03
-0.15 (-0.99%)
-0.15 (-0.99%)Volume
3,731,605
52 week range
12.99 - 18.90
- Open14.84
- Day High15.09
- Day Low14.84
- Prev Close15.18
- 52 Week High18.90
- 52 Week High Date04/01/26
- 52 Week Low12.99
- 52 Week Low Date10/30/25
Latest On Takeda Pharmaceutical Co Ltd
Key Stats
- Market Cap47.833B
- Shares Out3.18B
- 10 Day Average Volume2.99M
- Dividend0.66
- Dividend Yield4.40%
- Beta-0.04
Latest On Takeda Pharmaceutical Co Ltd
KEY STATS
- Open14.84
- Day High15.09
- Day Low14.84
- Prev Close15.18
- 52 Week High18.90
- 52 Week High Date04/01/26
- 52 Week Low12.99
- 52 Week Low Date10/30/25
- Market Cap47.833B
- Shares Out3.18B
- 10 Day Average Volume2.99M
- Dividend0.66
- Dividend Yield4.40%
- Beta-0.04
RATIOS/PROFITABILITY
- EPS (TTM)0.38
- P/E (TTM)39.05
- Fwd P/E (NTM)4.88
- EBITDA (TTM)7.59B
- ROE (TTM)2.61%
- Revenue (TTM)28.222B
- Gross Margin (TTM)65.12%
- Net Margin (TTM)4.26%
- Debt To Equity (MRQ)62.80%
EVENTS
- Earnings Date07/31/2026(est)
- Ex Div Date09/30/2025
- Div Amount0.3221
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORETakeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Milano Furuta
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan